Showing 361 - 380 results of 116,331 for search '(( a non decrease ) OR ( 5 ((((mean decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.67s Refine Results
  1. 361
  2. 362

    The 2lox Lsd1 variant shows decreased binding to known interactors. by Thomas B. Nicholson (406800)

    Published 2013
    “…For the two single point mutants, the M448V mutation has a more profound effect on CoREST binding. *: immunoglobulin heavy chain. …”
  3. 363
  4. 364
  5. 365

    Deletion of STX1B decreases the size of RRP in glutamatergic and GABAergic synapses. by Tatsuya Mishima (529071)

    Published 2014
    “…<p>(A) Average EPSC evoked by application of 0.5 M hypertonic sucrose solution for 15 s in WT and STX1B<sup>−/−</sup> neurons (left). …”
  6. 366

    Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism-3 by John H Boyd (88940)

    Published 2011
    “…Group mean absorbance data taken at the plateau fibrinogen concentration (100 μM) demonstrating a strong interaction between the ICAM-1 (8–22) peptide and fibrinogen compared with a small non-specific interaction between the scrambled peptide and fibrinogen. *< 0.05 versus scrambled peptide.…”
  7. 367
  8. 368
  9. 369

    Disruption of bacterial K<sup>+</sup> homeostasis decreases Mtb colonization of macrophages. by Nathan J. MacGilvary (6294314)

    Published 2019
    “…Each point on the graph represents a bacterium or a tight cluster of bacteria (black circles—WT, red squares– Δ<i>ceoBC</i>, blue triangles—<i>ceoBC</i>*). p-values were obtained with a Mann-Whitney statistical test. …”
  10. 370
  11. 371
  12. 372

    Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…In the recurrence group, BCVA (logMAR) showed no significant improvement over time: 0.37 ± 0.20 preoperatively and 0.35 ± 0.23, 0.35 ± 0.18, 0.31 ± 0.23, 0.34 ± 0.26, 0.28 ± 0.30, and 0.24 ± 0.23 at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, p = 0.45). In contrast, the non-recurrence group demonstrated significant and sustained improvement from 0.31 ± 0.25 preoperatively to 0.25 ± 0.25, 0.23 ± 0.26, 0.23 ± 0.28, 0.21 ± 0.27, 0.20 ± 0.30, and 0.16 ± 0.30 at corresponding postoperative time points (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g005" target="_blank">Fig 5</a>).…”
  13. 373
  14. 374
  15. 375
  16. 376
  17. 377
  18. 378

    Transforming growth factor (TGF)-β1 induced a robust decrease in S-phase in non-cancer cell strains by Kimberly A Brown (26546)

    Published 2011
    “…Representative histograms are presented illustrating cells that had a robust decrease in S-phase (NMuMG), modest decrease in S-phase (EpH4), and no decrease in S-phase (MDA-MB-436) as a result of TGF-βtreatment. …”
  19. 379
  20. 380